Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver

Han-Yu Lei,Ying-He Ding,Kai Nie,Yin-Miao Dong,Jia-Hao Xu,Meng-Ling Yang,Meng-Qi Liu,Le Wei,M I Nasser,Lin-Yong Xu,Ping Zhu,Ming-Yi Zhao,MI Nasser

DOI: https://doi.org/10.1016/j.biopha.2020.111064

2021-01-01

Abstract:<p>COVID-19 is a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early reported symptoms include fever, cough, and respiratory symptoms. There were few reports of digestive symptoms. However, with COVID-19 spreading worldwide, symptoms such as vomiting, diarrhoea, and abdominal pain have gained increasing attention. Research has found that angiotensin-converting enzyme 2 (ACE2), the SARS-CoV-2 receptor, is strongly expressed in the gastrointestinal tract and liver. Whether theoretically or clinically, many studies have suggested a close connection between COVID-19 and the digestive system. In this review, we summarize the digestive symptoms reported in existing research, discuss the impact of SARS-CoV-2 on the gastrointestinal tract and liver, and determine the possible mechanisms and aetiology, such as cytokine storm. In-depth exploration of the relationship between COVID-19 and the digestive system is urgently needed.</p>

pharmacology & pharmacy,medicine, research & experimental

What problem does this paper attempt to address?

This paper attempts to explore the potential impacts of SARS - CoV - 2 on the gastrointestinal tract and liver. Specifically, the paper focuses on the following aspects:

1. **Reports of digestive system symptoms**: The paper summarizes the digestive system symptoms of COVID - 19 patients reported in existing studies, such as diarrhea, anorexia, nausea, vomiting, abdominal pain and gastrointestinal bleeding, etc., and discusses the incidence of these symptoms.

2. **Cytopathic effects caused by the virus through ACE2 receptors**: The study found that SARS - CoV - 2 enters cells through ACE2 receptors, especially the ACE2 receptors that are abundantly expressed in the gastrointestinal tract and liver, which may lead to cell damage and inflammatory reactions.

3. **Immune - mediated cytokine storm**: The paper discusses the cytokine storm that may occur in patients after SARS - CoV - 2 infection. This excessive immune response will lead to acute respiratory distress syndrome (ARDS) and other multi - organ dysfunctions.

4. **Pathological connection between the microbiota and the gut - lung axis**: The paper explores the role of the gut microbiota in the development of COVID - 19 and the mutual influence between the gut and the lungs.

5. **Prognosis of patients with pre - existing gastrointestinal diseases**: The paper analyzes the prognosis of patients with pre - existing gastrointestinal diseases after being infected with COVID - 19, especially the increased risk of patients with inflammatory bowel disease (IBD).

6. **Clinical features and pathological changes of liver injury**: The paper describes in detail the clinical manifestations and pathological changes of liver injury in COVID - 19 patients, including indicators such as elevated liver enzyme levels and elevated bilirubin levels.

7. **Direct viral infection**: The paper discusses the possibility of SARS - CoV - 2 directly infecting liver cells, especially the high expression of ACE2 receptors in cholangiocytes.

8. **Drug - induced hepatotoxicity**: The paper explores the liver injury that may be caused by drugs (such as remdesivir) used to treat COVID - 19.

9. **COVID - 19 risks for liver transplant recipients**: The paper pays special attention to the special risks and treatment strategies of liver transplant recipients after being infected with SARS - CoV - 2.

10. **Prognosis of patients with pre - existing liver diseases**: The paper analyzes the prognosis of patients with pre - existing liver diseases after being infected with COVID - 19, especially the significantly increased mortality rate of patients with cirrhosis.

Overall, this paper aims to comprehensively explore the potential impacts of SARS - CoV - 2 on the gastrointestinal tract and liver, as well as the possible mechanisms behind these impacts, and provide a scientific basis for future prevention and treatment.